Document is current
Any future updates will be listed below
-
Authors
Knoll, Rebecca Luise https://orcid.org/0000-0002-3496-345X
Brauny, Melanie Meihua
Robert, Evelyn
Cloos, Louisa
Waser, Lydia
Hilbert, Katja
Ulmer, Nina https://orcid.org/0009-0006-3556-9645
Hillen, Barlo
Birkner, Till https://orcid.org/0000-0003-2656-2821
Bartolomaeus, Theda Ulrike Patricia
Nitsche, Oliver
Jarquín-Díaz, Víctor Hugo https://orcid.org/0000-0003-3758-1091
Lynch, Susan https://orcid.org/0000-0001-5695-7336
Gehring, Stephan
Maier, Lisa https://orcid.org/0000-0002-6473-4762
Poplawska, Krystyna https://orcid.org/0000-0003-4701-3784
Forslund-Startceva, Sofia Kirke https://orcid.org/0000-0003-4285-6993
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (551589343)
Deutsche Forschungsgemeinschaft (FO 1279/6-1, Project ID 431232613 – SFB 1449 ()
- License Information
-
More Information
Article History
Received: 2 February 2025
Accepted: 8 September 2025
First Online: 18 November 2025
Competing interests
: Krystyna Poplawska served on the advisory board of Vertex Pharmaceuticals Inc. All other authors have no conflicts of interest to declare.
